1. Home
  2. TBI vs KPTI Comparison

TBI vs KPTI Comparison

Compare TBI & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

HOLD

Current Price

$6.63

Market Cap

205.5M

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$9.08

Market Cap

194.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBI
KPTI
Founded
1985
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.5M
194.8M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
TBI
KPTI
Price
$6.63
$9.08
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$6.00
$16.00
AVG Volume (30 Days)
300.4K
466.1K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
61.39
N/A
EPS
N/A
N/A
Revenue
N/A
$146,067,000.00
Revenue This Year
$6.25
N/A
Revenue Next Year
$3.90
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.57
52 Week Low
$3.18
$3.65
52 Week High
$7.78
$10.99

Technical Indicators

Market Signals
Indicator
TBI
KPTI
Relative Strength Index (RSI) 67.05 54.69
Support Level $5.44 $5.43
Resistance Level $6.61 $9.45
Average True Range (ATR) 0.40 0.73
MACD 0.05 0.05
Stochastic Oscillator 71.96 70.29

Price Performance

Historical Comparison
TBI
KPTI

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: